Search Results

There are 12408 results for: content related to: Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats

  1. The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

    Movement Disorders

    Volume 31, Issue 8, August 2016, Pages: 1080–1094, Raul Martínez-Fernández, Emmanuelle Schmitt, Pablo Martinez-Martin and Paul Krack

    Version of Record online : 19 JUL 2016, DOI: 10.1002/mds.26731

  2. The focal dystonias: Current views and challenges for future research

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 926–943, H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter, Ami R. Rosen and for the Dystonia Coalition Investigators

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25567

  3. Neuropathology of multiple system atrophy: New thoughts about pathogenesis

    Movement Disorders

    Volume 29, Issue 14, December 2014, Pages: 1720–1741, Kurt A. Jellinger

    Version of Record online : 9 OCT 2014, DOI: 10.1002/mds.26052

  4. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 861–881, Manuel Delgado-Alvarado, Belén Gago, Irene Navalpotro-Gomez, Haritz Jiménez-Urbieta and María C. Rodriguez-Oroz

    Version of Record online : 19 MAY 2016, DOI: 10.1002/mds.26662

  5. “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide

    Movement Disorders

    Volume 28, Issue 9, August 2013, Pages: 1184–1199, Maria Stamelou, Niall P. Quinn and Kailash P. Bhatia

    Version of Record online : 29 MAY 2013, DOI: 10.1002/mds.25509

  6. You have free access to this content
    The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease

    Movement Disorders

    Volume 31, Issue 1, January 2016, Pages: 23–38, Gretchen O. Reynolds, Michael W. Otto, Terry D. Ellis and Alice Cronin-Golomb

    Version of Record online : 30 DEC 2015, DOI: 10.1002/mds.26484

  7. Behavioral effects of levodopa

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 90–102, Isabelle Beaulieu-Boire and Anthony E. Lang

    Version of Record online : 9 DEC 2014, DOI: 10.1002/mds.26121

  8. The medical treatment of Parkinson disease from James Parkinson to George Cotzias

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 4–18, Stanley Fahn

    Version of Record online : 9 DEC 2014, DOI: 10.1002/mds.26102

  9. Improving l-dopa therapy: The development of enzyme inhibitors

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 103–113, Oscar S. Gershanik

    Version of Record online : 21 OCT 2014, DOI: 10.1002/mds.26050

  10. Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?

    Movement Disorders

    Volume 29, Issue 11, 15 September 2014, Pages: 1404–1413, Annie Killoran and Kevin M. Biglan

    Version of Record online : 27 AUG 2014, DOI: 10.1002/mds.26014

  11. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force

    Movement Disorders

    Volume 31, Issue 4, April 2016, Pages: 436–457, Connie Marras, Anthony Lang, Bart P. van de Warrenburg, Carolyn M. Sue, Sarah J. Tabrizi, Lars Bertram, Saadet Mercimek-Mahmutoglu, Darius Ebrahimi-Fakhari, Thomas T. Warner, Alexandra Durr, Birgit Assmann, Katja Lohmann, Vladimir Kostic and Christine Klein

    Version of Record online : 15 APR 2016, DOI: 10.1002/mds.26527

  12. Biomarkers for trials of neuroprotection in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 1, January 2013, Pages: 71–85, Pankaj A. Agarwal and A. Jon Stoessl

    Version of Record online : 24 AUG 2012, DOI: 10.1002/mds.25065

  13. Medical treatment of dystonia

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 1001–1012, Joseph Jankovic

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25552

  14. Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 791–801, Tim Moors, Silvia Paciotti, Davide Chiasserini, Paolo Calabresi, Lucilla Parnetti, Tommaso Beccari and Wilma D. J. van de Berg

    Version of Record online : 29 FEB 2016, DOI: 10.1002/mds.26562

  15. The anatomical basis of dystonia: Current view using neuroimaging

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 944–957, Stéphane Lehéricy, Marina A.J. Tijssen, Marie Vidailhet, Ryuji Kaji and Sabine Meunier

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25527

  16. Glycation in Parkinson's disease and Alzheimer's disease

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 782–790, Hugo Vicente Miranda, Omar M. A. El-Agnaf and Tiago Fleming Outeiro

    Version of Record online : 4 MAR 2016, DOI: 10.1002/mds.26566

  17. Dopamine signals and physiological origin of cognitive dysfunction in Parkinson's disease

    Movement Disorders

    Volume 30, Issue 4, April 2015, Pages: 472–483, Masayuki Matsumoto

    Version of Record online : 15 MAR 2015, DOI: 10.1002/mds.26177

  18. Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders

    Movement Disorders

    Volume 30, Issue 9, August 2015, Pages: 1155–1170, Léon Tremblay, Yulia Worbe, Stéphane Thobois, Véronique Sgambato-Faure and Jean Féger

    Version of Record online : 15 MAR 2015, DOI: 10.1002/mds.26199

  19. Parkinson's Disease, the Subthalamic Nucleus, Inhibition, and Impulsivity

    Movement Disorders

    Volume 30, Issue 2, February 2015, Pages: 128–140, Marjan Jahanshahi, Ignacio Obeso, Christelle Baunez, Manuel Alegre and Paul Krack

    Version of Record online : 9 OCT 2014, DOI: 10.1002/mds.26049

  20. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 771–781, Gianluigi Forloni, Vladimiro Artuso, Pietro La Vitola and Claudia Balducci

    Version of Record online : 31 MAR 2016, DOI: 10.1002/mds.26624